» Articles » PMID: 35139878

The Effects of Extracellular Vesicles Derived from Krüppel-Like Factor 2 Overexpressing Endothelial Cells on the Regulation of Cardiac Inflammation in the Dilated Cardiomyopathy

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2022 Feb 10
PMID 35139878
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dilated cardiomyopathy (DCM) is one of the common causes of heart failure. Myocardial injury triggers an inflammatory response and recruits immune cells into the heart. High expression of Krüppel-like factor 2 (KLF2) in endothelial cells (ECs) potentially exerts an anti-inflammatory effect. However, the role of extracellular vesicles (EVs) from KLF2-overexpressing ECs (KLF2-EVs) in DCM remains unclear.

Methods And Results: EVs were separated from the supernatant of KLF2-overexpressing ECs by gradient centrifugation. Mice were repeatedly administered low-dose doxorubicin (DOX) and then received KLF2-EVs through an intravenous injection. Treatment with KLF2-EVs prevented doxorubicin-induced left ventricular dysfunction and reduced the recruitment of Ly6 Mo/Mø in the myocardium. We used flow cytometry to detect Ly6 monocytes in bone marrow and spleen tissues and to elucidate the mechanisms underlying this beneficial effect. KLF2-EVs increased the retention of Ly6C monocytes in the bone marrow but not in the spleen tissue. KLF2-EVs also significantly downregulated C-C chemokine receptor 2 (CCR2) protein expression in cells from the bone marrow.

Conclusions: EVs derived from KLF2-overexpressing ECs reduced cardiac inflammation and ameliorated left ventricular dysfunction in DCM mice by targeting the CCR2 protein to inhibit Ly6C monocyte mobilization from the bone marrow.

Citing Articles

Small Extracellular Vesicles from Breast Cancer Cells Induce Cardiotoxicity.

Osorio-Mendez J, Gomez-Grosso L, Montoya-Ortiz G, Novoa-Herran S, Dominguez-Romero Y Int J Mol Sci. 2025; 26(3).

PMID: 39940718 PMC: 11816698. DOI: 10.3390/ijms26030945.


Krüpple-like factors in cardiomyopathy: emerging player and therapeutic opportunities.

Gui L, Liu H, Jin L, Peng X Front Cardiovasc Med. 2024; 11:1342173.

PMID: 38516000 PMC: 10955087. DOI: 10.3389/fcvm.2024.1342173.


Unraveling the Signaling Dynamics of Small Extracellular Vesicles in Cardiac Diseases.

Cano-Carrillo S, Castillo-Casas J, Franco D, Lozano-Velasco E Cells. 2024; 13(3.

PMID: 38334657 PMC: 10854837. DOI: 10.3390/cells13030265.


Extracellular vesicles in cardiomyopathies: A narrative review.

Rizzuto A, Faggiano A, Macchi C, Carugo S, Perrino C, Ruscica M Heliyon. 2024; 10(1):e23765.

PMID: 38192847 PMC: 10772622. DOI: 10.1016/j.heliyon.2023.e23765.


Extracellular Vesicles: A New Frontier for Cardiac Repair.

You B, Yang Y, Zhou Z, Yan Y, Zhang L, Jin J Pharmaceutics. 2022; 14(9).

PMID: 36145595 PMC: 9503573. DOI: 10.3390/pharmaceutics14091848.


References
1.
Mincheva-Nilsson L, Baranov V, Nagaeva O, Dehlin E . Isolation and Characterization of Exosomes from Cultures of Tissue Explants and Cell Lines. Curr Protoc Immunol. 2016; 115:14.42.1-14.42.21. DOI: 10.1002/cpim.17. View

2.
Song H, Li X, Zhao Z, Qian J, Wang Y, Cui J . Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes. Nano Lett. 2019; 19(5):3040-3048. DOI: 10.1021/acs.nanolett.9b00287. View

3.
Sun X, Shan A, Wei Z, Xu B . Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy. Biochem Biophys Res Commun. 2018; 503(4):2611-2618. DOI: 10.1016/j.bbrc.2018.08.012. View

4.
Mann D . Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res. 2015; 116(7):1254-68. PMC: 4380242. DOI: 10.1161/CIRCRESAHA.116.302317. View

5.
Leuschner F, Rauch P, Ueno T, Gorbatov R, Marinelli B, Lee W . Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med. 2012; 209(1):123-37. PMC: 3260875. DOI: 10.1084/jem.20111009. View